Literature DB >> 24044897

Cytosolic phospholipase A2α upregulation mediates apoptotic neuronal death induced by aggregated amyloid-β peptide1-42.

Chen Sagy-Bross1, Nurit Hadad1, Rachel Levy2.   

Abstract

Increased cytosolic phospholipase A2α (cPLA2α) immunoreactivity and transcript were observed in Alzheimer's disease (AD) brain associated with amyloid deposits. Thus, the present study examined whether cPLA2α upregulation participate in cortical neuron damage induced by aggregated Aβ1-42 and determined its role in the signaling events leading to damage, using an antisense technology. Exposure of primary cortical neurons to 1μM aggregated Aβ1-42 for 24h induced up-regulation and activation of cPLA2α and apoptotic cell death of about 30% as detected by: cell count, MTT reduction, caspases-3 and -8 activation, DAPI and TUNEL staining, that were prevented by inhibition of cPLA2α up-regulation and activity in the presence of antisense against cPLA2α (AS). cPLA2α was rapidly activated upon addition of aggregated Aβ1-42, as determined by its phosphorylated form on serine 505, and this activity was dependent on NADPH oxidase activity. NOX2- and NOX4-NADPH oxidase upregulation at 24h of aggregated Aβ1-42 exposure was not affected by the presence of AS, but superoxide production was reduced, probably due to NOX2 inhibition. cPLA2α upregulation led to activation of neutral sphingomyelinase (N-SMase) as its activity was inhibited in the presence of AS, and could be restored by addition of arachidonic acid. Addition of ceramide analog induced caspase-8 activation leading to caspase-3 activation and apoptotic neuronal death. In conclusion, our results suggest that cPLA2α activity plays a crucial role in the signaling cascade leading to apoptotic neuronal death by aggregated Aβ1-42 probably via activation of N-SMase, ceramide production and caspases-3 and -8.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Apoptosis; Arachidonic acid; Caspases; Cortical neurons; Cytosolic phospholipase A(2)α; NADPH oxidase

Mesh:

Substances:

Year:  2013        PMID: 24044897     DOI: 10.1016/j.neuint.2013.09.007

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  14 in total

1.  Combination of EPA with Carotenoids and Polyphenol Synergistically Attenuated the Transformation of Microglia to M1 Phenotype Via Inhibition of NF-κB.

Authors:  Nurit Hadad; Rachel Levy
Journal:  Neuromolecular Med       Date:  2017-08-04       Impact factor: 3.843

2.  Ginsenoside Rg1 and Acori Graminei Rhizoma Attenuates Neuron Cell Apoptosis by Promoting the Expression of miR-873-5p in Alzheimer's Disease.

Authors:  Ran Shi; Sishuo Zhang; Guangqing Cheng; Xiaoni Yang; Ningning Zhao; Chao Chen
Journal:  Neurochem Res       Date:  2018-06-20       Impact factor: 3.996

3.  The juxtamembrane linker in neutral sphingomyelinase-2 functions as an intramolecular allosteric switch that activates the enzyme.

Authors:  Prajna Shanbhogue; Reece M Hoffmann; Michael V Airola; Rohan Maini; David J Hamelin; Miguel Garcia-Diaz; John E Burke; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2019-03-19       Impact factor: 5.157

Review 4.  Therapeutic implications of the prostaglandin pathway in Alzheimer's disease.

Authors:  Eiron Cudaback; Nikolas L Jorstad; Yue Yang; Thomas J Montine; C Dirk Keene
Journal:  Biochem Pharmacol       Date:  2014-01-13       Impact factor: 5.858

Review 5.  Role of cytosolic phospholipase A2 in oxidative and inflammatory signaling pathways in different cell types in the central nervous system.

Authors:  Grace Y Sun; Dennis Y Chuang; Yijia Zong; Jinghua Jiang; James C M Lee; Zezong Gu; Agnes Simonyi
Journal:  Mol Neurobiol       Date:  2014-02-27       Impact factor: 5.590

6.  Amyloid-β and proinflammatory cytokines utilize a prion protein-dependent pathway to activate NADPH oxidase and induce cofilin-actin rods in hippocampal neurons.

Authors:  Keifer P Walsh; Laurie S Minamide; Sarah J Kane; Alisa E Shaw; David R Brown; Bruce Pulford; Mark D Zabel; J David Lambeth; Thomas B Kuhn; James R Bamburg
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

7.  β-Sheet Breaker Peptide-HPYD for the Treatment of Alzheimer's Disease: Primary Studies on Behavioral Test and Transcriptional Profiling.

Authors:  Weiying Liu; Fengxian Sun; Moxin Wan; Fang Jiang; Xiangyu Bo; Laixiang Lin; Hua Tang; Shumei Xu
Journal:  Front Pharmacol       Date:  2018-01-08       Impact factor: 5.810

8.  Lumenato protects normal human dermal fibroblasts from neutrophil-induced collagen-3 damage in co-cultures.

Authors:  Yulia Solomonov; Nurit Hadad; Oleg Pikovsky; Rachel Levy
Journal:  PLoS One       Date:  2021-03-17       Impact factor: 3.240

9.  miR-204-3p/Nox4 Mediates Memory Deficits in a Mouse Model of Alzheimer's Disease.

Authors:  Wenyuan Tao; Linjie Yu; Shu Shu; Ying Liu; Zi Zhuang; Siyi Xu; Xinyu Bao; Yue Gu; Fang Cai; Weihong Song; Yun Xu; Xiaolei Zhu
Journal:  Mol Ther       Date:  2020-09-05       Impact factor: 11.454

10.  Reduction of cytosolic phospholipase A2α upregulation delays the onset of symptoms in SOD1G93A mouse model of amyotrophic lateral sclerosis.

Authors:  Yulia Solomonov; Nurit Hadad; Rachel Levy
Journal:  J Neuroinflammation       Date:  2016-06-01       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.